BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Total Liabilities (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Total Liabilities of $3.82 billion for Q3 2026, up 30.9% from $2.92 billion a year earlier and up 2.7% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Total Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma posted Total Liabilities of $3.02 billion, up 27.2% from FY2024.

  • Total Liabilities has increased for three consecutive years, with a five-year compound annual growth rate of 38.3% (FY2020 to FY2025).
  • By year, Total Liabilities came in at $2.38 billion in FY2024 (+25.8%), $1.89 billion in FY2023 (+1.2%), $1.87 billion in FY2022 (-0.7%) and $1.88 billion in FY2021 (+214.7%).
  • The Q3 2026 figure ranks as the highest quarterly Total Liabilities in data going back to Q4 2018.
  • Year over year, Total Liabilities has now increased in each of the last 12 quarters, with growth averaging 37.4% over the last eight quarters.
  • The high point for year-over-year Total Liabilities in five years was Q4 2021 (growth of 214.7%); the low point was Q2 2023 (a decline of 1.2%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $3.72 billion (Q2 2026), $3.64 billion (Q1 2026) and $3.02 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 115.90 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 152.26 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 38.37 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.70 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 3.82 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.82 Bn
Jun 30, 2026 3.72 Bn
Mar 31, 2026 3.64 Bn
Dec 31, 2025 3.02 Bn
Sep 30, 2025 2.92 Bn
Jun 30, 2025 2.86 Bn
Mar 31, 2025 2.52 Bn
Dec 31, 2024 2.38 Bn
Sep 30, 2024 1.88 Bn
Jun 30, 2024 1.88 Bn
Mar 31, 2024 1.89 Bn
Dec 31, 2023 1.89 Bn
Sep 30, 2023 1.85 Bn
Jun 30, 2023 1.85 Bn
Mar 31, 2023 1.84 Bn
Dec 31, 2022 1.87 Bn
Sep 30, 2022 1.86 Bn
Jun 30, 2022 1.88 Bn
Mar 31, 2022 1.85 Bn
Dec 31, 2021 1.88 Bn
API Access

BridgeBio Pharma Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=BBIO&period=max&api_key=YOUR_API_KEY